COPD and Asthma Drug Devices or dry powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus.
The global COPD and Asthma Drug Devices market is projected to grow from US$ 251.4 million in 2024 to US$ 369.4 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.6% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for COPD and Asthma Drug Devices, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of COPD and Asthma Drug Devices, also provides the sales of main regions and countries. Highlights of the upcoming market potential for COPD and Asthma Drug Devices, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the COPD and Asthma Drug Devices sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global COPD and Asthma Drug Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for COPD and Asthma Drug Devices sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
AstraZeneca
GlaxoSmithKline
3M Healthcare
GF Health Products, Inc
Sunovion Pharmaceuticals Inc.
Smith Medicals, Inc.
Baxter International
Koninklijke Philips N.V.
Segment by Type
COPD & Asthma Inhaler
COPD & Asthma Nebulizer
Segment by Application
Hospitals
Clinics
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of COPD and Asthma Drug Devices in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of COPD and Asthma Drug Devices manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, COPD and Asthma Drug Devices sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 COPD and Asthma Drug Devices Product Introduction
1.2 Market by Type
1.2.1 Global COPD and Asthma Drug Devices Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 COPD & Asthma Inhaler
1.2.3 COPD & Asthma Nebulizer
1.3 Market by Application
1.3.1 Global COPD and Asthma Drug Devices Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global COPD and Asthma Drug Devices Sales Estimates and Forecasts 2019-2030
2.2 Global COPD and Asthma Drug Devices Revenue by Region
2.2.1 Global COPD and Asthma Drug Devices Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global COPD and Asthma Drug Devices Revenue by Region (2019-2024)
2.2.3 Global COPD and Asthma Drug Devices Revenue by Region (2025-2030)
2.2.4 Global COPD and Asthma Drug Devices Revenue Market Share by Region (2019-2030)
2.3 Global COPD and Asthma Drug Devices Sales Estimates and Forecasts 2019-2030
2.4 Global COPD and Asthma Drug Devices Sales by Region
2.4.1 Global COPD and Asthma Drug Devices Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global COPD and Asthma Drug Devices Sales by Region (2019-2024)
2.4.3 Global COPD and Asthma Drug Devices Sales by Region (2025-2030)
2.4.4 Global COPD and Asthma Drug Devices Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global COPD and Asthma Drug Devices Sales by Manufacturers
3.1.1 Global COPD and Asthma Drug Devices Sales by Manufacturers (2019-2024)
3.1.2 Global COPD and Asthma Drug Devices Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of COPD and Asthma Drug Devices in 2023
3.2 Global COPD and Asthma Drug Devices Revenue by Manufacturers
3.2.1 Global COPD and Asthma Drug Devices Revenue by Manufacturers (2019-2024)
3.2.2 Global COPD and Asthma Drug Devices Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by COPD and Asthma Drug Devices Revenue in 2023
3.3 Global Key Players of COPD and Asthma Drug Devices, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global COPD and Asthma Drug Devices Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global COPD and Asthma Drug Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of COPD and Asthma Drug Devices, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of COPD and Asthma Drug Devices, Product Offered and Application
3.8 Global Key Manufacturers of COPD and Asthma Drug Devices, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global COPD and Asthma Drug Devices Sales by Type
4.1.1 Global COPD and Asthma Drug Devices Historical Sales by Type (2019-2024)
4.1.2 Global COPD and Asthma Drug Devices Forecasted Sales by Type (2025-2030)
4.1.3 Global COPD and Asthma Drug Devices Sales Market Share by Type (2019-2030)
4.2 Global COPD and Asthma Drug Devices Revenue by Type
4.2.1 Global COPD and Asthma Drug Devices Historical Revenue by Type (2019-2024)
4.2.2 Global COPD and Asthma Drug Devices Forecasted Revenue by Type (2025-2030)
4.2.3 Global COPD and Asthma Drug Devices Revenue Market Share by Type (2019-2030)
4.3 Global COPD and Asthma Drug Devices Price by Type
4.3.1 Global COPD and Asthma Drug Devices Price by Type (2019-2024)
4.3.2 Global COPD and Asthma Drug Devices Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global COPD and Asthma Drug Devices Sales by Application
5.1.1 Global COPD and Asthma Drug Devices Historical Sales by Application (2019-2024)
5.1.2 Global COPD and Asthma Drug Devices Forecasted Sales by Application (2025-2030)
5.1.3 Global COPD and Asthma Drug Devices Sales Market Share by Application (2019-2030)
5.2 Global COPD and Asthma Drug Devices Revenue by Application
5.2.1 Global COPD and Asthma Drug Devices Historical Revenue by Application (2019-2024)
5.2.2 Global COPD and Asthma Drug Devices Forecasted Revenue by Application (2025-2030)
5.2.3 Global COPD and Asthma Drug Devices Revenue Market Share by Application (2019-2030)
5.3 Global COPD and Asthma Drug Devices Price by Application
5.3.1 Global COPD and Asthma Drug Devices Price by Application (2019-2024)
5.3.2 Global COPD and Asthma Drug Devices Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada COPD and Asthma Drug Devices Market Size by Type
6.1.1 US & Canada COPD and Asthma Drug Devices Sales by Type (2019-2030)
6.1.2 US & Canada COPD and Asthma Drug Devices Revenue by Type (2019-2030)
6.2 US & Canada COPD and Asthma Drug Devices Market Size by Application
6.2.1 US & Canada COPD and Asthma Drug Devices Sales by Application (2019-2030)
6.2.2 US & Canada COPD and Asthma Drug Devices Revenue by Application (2019-2030)
6.3 US & Canada COPD and Asthma Drug Devices Market Size by Country
6.3.1 US & Canada COPD and Asthma Drug Devices Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada COPD and Asthma Drug Devices Sales by Country (2019-2030)
6.3.3 US & Canada COPD and Asthma Drug Devices Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe COPD and Asthma Drug Devices Market Size by Type
7.1.1 Europe COPD and Asthma Drug Devices Sales by Type (2019-2030)
7.1.2 Europe COPD and Asthma Drug Devices Revenue by Type (2019-2030)
7.2 Europe COPD and Asthma Drug Devices Market Size by Application
7.2.1 Europe COPD and Asthma Drug Devices Sales by Application (2019-2030)
7.2.2 Europe COPD and Asthma Drug Devices Revenue by Application (2019-2030)
7.3 Europe COPD and Asthma Drug Devices Market Size by Country
7.3.1 Europe COPD and Asthma Drug Devices Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe COPD and Asthma Drug Devices Sales by Country (2019-2030)
7.3.3 Europe COPD and Asthma Drug Devices Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China COPD and Asthma Drug Devices Market Size
8.1.1 China COPD and Asthma Drug Devices Sales (2019-2030)
8.1.2 China COPD and Asthma Drug Devices Revenue (2019-2030)
8.2 China COPD and Asthma Drug Devices Market Size by Application
8.2.1 China COPD and Asthma Drug Devices Sales by Application (2019-2030)
8.2.2 China COPD and Asthma Drug Devices Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia COPD and Asthma Drug Devices Market Size by Type
9.1.1 Asia COPD and Asthma Drug Devices Sales by Type (2019-2030)
9.1.2 Asia COPD and Asthma Drug Devices Revenue by Type (2019-2030)
9.2 Asia COPD and Asthma Drug Devices Market Size by Application
9.2.1 Asia COPD and Asthma Drug Devices Sales by Application (2019-2030)
9.2.2 Asia COPD and Asthma Drug Devices Revenue by Application (2019-2030)
9.3 Asia COPD and Asthma Drug Devices Sales by Region
9.3.1 Asia COPD and Asthma Drug Devices Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia COPD and Asthma Drug Devices Revenue by Region (2019-2030)
9.3.3 Asia COPD and Asthma Drug Devices Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America COPD and Asthma Drug Devices Market Size by Type
10.1.1 Middle East, Africa and Latin America COPD and Asthma Drug Devices Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America COPD and Asthma Drug Devices Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America COPD and Asthma Drug Devices Market Size by Application
10.2.1 Middle East, Africa and Latin America COPD and Asthma Drug Devices Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America COPD and Asthma Drug Devices Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America COPD and Asthma Drug Devices Sales by Country
10.3.1 Middle East, Africa and Latin America COPD and Asthma Drug Devices Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America COPD and Asthma Drug Devices Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America COPD and Asthma Drug Devices Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Novartis International AG
11.1.1 Novartis International AG Company Information
11.1.2 Novartis International AG Overview
11.1.3 Novartis International AG COPD and Asthma Drug Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Novartis International AG COPD and Asthma Drug Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis International AG Recent Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Overview
11.2.3 Merck COPD and Asthma Drug Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Merck COPD and Asthma Drug Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Recent Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Information
11.3.2 AstraZeneca Overview
11.3.3 AstraZeneca COPD and Asthma Drug Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 AstraZeneca COPD and Asthma Drug Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 AstraZeneca Recent Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Information
11.4.2 GlaxoSmithKline Overview
11.4.3 GlaxoSmithKline COPD and Asthma Drug Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 GlaxoSmithKline COPD and Asthma Drug Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 GlaxoSmithKline Recent Developments
11.5 3M Healthcare
11.5.1 3M Healthcare Company Information
11.5.2 3M Healthcare Overview
11.5.3 3M Healthcare COPD and Asthma Drug Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 3M Healthcare COPD and Asthma Drug Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 3M Healthcare Recent Developments
11.6 GF Health Products, Inc
11.6.1 GF Health Products, Inc Company Information
11.6.2 GF Health Products, Inc Overview
11.6.3 GF Health Products, Inc COPD and Asthma Drug Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 GF Health Products, Inc COPD and Asthma Drug Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 GF Health Products, Inc Recent Developments
11.7 Sunovion Pharmaceuticals Inc.
11.7.1 Sunovion Pharmaceuticals Inc. Company Information
11.7.2 Sunovion Pharmaceuticals Inc. Overview
11.7.3 Sunovion Pharmaceuticals Inc. COPD and Asthma Drug Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Sunovion Pharmaceuticals Inc. COPD and Asthma Drug Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sunovion Pharmaceuticals Inc. Recent Developments
11.8 Smith Medicals, Inc.
11.8.1 Smith Medicals, Inc. Company Information
11.8.2 Smith Medicals, Inc. Overview
11.8.3 Smith Medicals, Inc. COPD and Asthma Drug Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Smith Medicals, Inc. COPD and Asthma Drug Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Smith Medicals, Inc. Recent Developments
11.9 Baxter International
11.9.1 Baxter International Company Information
11.9.2 Baxter International Overview
11.9.3 Baxter International COPD and Asthma Drug Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Baxter International COPD and Asthma Drug Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Baxter International Recent Developments
11.10 Koninklijke Philips N.V.
11.10.1 Koninklijke Philips N.V. Company Information
11.10.2 Koninklijke Philips N.V. Overview
11.10.3 Koninklijke Philips N.V. COPD and Asthma Drug Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Koninklijke Philips N.V. COPD and Asthma Drug Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Koninklijke Philips N.V. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 COPD and Asthma Drug Devices Industry Chain Analysis
12.2 COPD and Asthma Drug Devices Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 COPD and Asthma Drug Devices Production Mode & Process
12.4 COPD and Asthma Drug Devices Sales and Marketing
12.4.1 COPD and Asthma Drug Devices Sales Channels
12.4.2 COPD and Asthma Drug Devices Distributors
12.5 COPD and Asthma Drug Devices Customers
13 Market Dynamics
13.1 COPD and Asthma Drug Devices Industry Trends
13.2 COPD and Asthma Drug Devices Market Drivers
13.3 COPD and Asthma Drug Devices Market Challenges
13.4 COPD and Asthma Drug Devices Market Restraints
14 Key Findings in The Global COPD and Asthma Drug Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Novartis International AG
Merck
AstraZeneca
GlaxoSmithKline
3M Healthcare
GF Health Products, Inc
Sunovion Pharmaceuticals Inc.
Smith Medicals, Inc.
Baxter International
Koninklijke Philips N.V.
听
听
*If Applicable.
